Advent Life Sciences will manage an impact investment vehicle for Harrington Discovery Institute.
US-based hospital and accelerator operator Harrington Discovery Institute (HDI) has set up an impact investment fund to be managed by venture capital firm Advent Life Sciences. The impact fund is structured alongside Advent Life Sciences’ third fund and brings a total of $215m of commitments to the firm. Advent-Harrington Impact Fund is set up as…
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.